INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 54 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7 | -75.0% | 34,545 | -80.4% | 0.00% | -66.7% |
| Q1 2023 | $28 | -24.3% | 176,529 | +165.3% | 0.00% | -40.0% |
| Q4 2022 | $37 | -99.7% | 66,537 | +300.0% | 0.01% | +400.0% |
| Q2 2022 | $11,000 | -94.1% | 16,636 | -79.8% | 0.00% | -94.7% |
| Q4 2021 | $185,000 | +54.2% | 82,316 | +134.1% | 0.02% | +72.7% |
| Q3 2021 | $120,000 | -65.2% | 35,166 | -69.5% | 0.01% | -67.6% |
| Q2 2021 | $345,000 | +70.0% | 115,312 | +83.1% | 0.03% | +142.9% |
| Q1 2021 | $203,000 | +1745.5% | 62,984 | +412.8% | 0.01% | +1300.0% |
| Q2 2020 | $11,000 | -59.3% | 12,283 | -55.8% | 0.00% | -66.7% |
| Q4 2019 | $27,000 | +35.0% | 27,796 | +157.6% | 0.00% | +200.0% |
| Q1 2019 | $20,000 | -39.4% | 10,791 | -61.1% | 0.00% | -50.0% |
| Q4 2018 | $33,000 | -77.9% | 27,706 | -60.9% | 0.00% | -75.0% |
| Q1 2018 | $149,000 | +964.3% | 70,854 | +585.3% | 0.01% | +700.0% |
| Q3 2017 | $14,000 | – | 10,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $4,017,000 | 0.19% |
| Gratus Capital, LLC | 1,117,154 | $706,000 | 0.08% |
| Bleichroeder LP | 250,000 | $158,000 | 0.03% |
| Polar Capital Holdings Plc | 5,000,000 | $3,162,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $345,000 | 0.01% |
| Ergoteles LLC | 419,652 | $265,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $157,000 | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 41,396 | $26,000 | 0.00% |
| Heritage Financial Services, LLC | 4,749 | $3,000 | 0.00% |
| Evercore Wealth Management, LLC | 143,138 | $91,000 | 0.00% |